Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0900 per EA under NDC 72888013201. Its NADAC has been published 146 times since Nov 8, 2023.
FDA first approved this application on Sep 13, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888013201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077661FDA Approved
9/13/2006
TE Code
AB1
On Market Since
9/22/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0900 per EA |
|---|---|
| All-time high | $0.1275 (Jan 10, 2024) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1029 |
| 52-week low | $0.0900 |
| Median price | $0.1017 |
| Average price | $0.1044 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 146 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0900 per EA (NDC 72888013201), effective Aug 19, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 28.0%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Nov 8, 2023, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1275 (Jan 10, 2024), with a median of $0.1017 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 72888013201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.